Download presentation
Presentation is loading. Please wait.
Published byChristal Hawkins Modified over 9 years ago
1
Total Synthesis and Evaluation of [ψ[CH 2 NH]Tpg 4 ] Vancomycin Aglycon: Reengineering Vancomycin for Dual D -Ala- D - Ala and D -Ala- D -Lac Binding Brendan M. Crowley and Dale L. Boger J. Am. Chem. Soc. 2006, 128, 2885-2892 Contribution from the Department of Chemistry and the Skaggs Institute for Chemical Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037 Presented by, Michael Elbaum
2
Dale L. Boger B.S. University of Kansas, 1975 Ph.D. Harvard University, 1980 Assistant / Associate Professor of Medicinal Chemistry, University of Kansas 1979-1985 Associate Professor / Professor of Chemistry, Purdue University, 1985-1991 Professor, The Scripps Research Institute, 1991-Present Member, The Skaggs Institute for Chemical Biology, 1996-present Editor-in-Chief, Bioorganic and Medicinal Chemistry Letter, 1990-present ACS Medicinal Chemistry Division, Councilor, 1996-1999 ACS Aldrich Award for Creativity in Organic Synthesis, 1999 ISI Highly Cited (top 100 chemists) 1
3
Vancomycin First isolated 1953 by Edmund Kornfeld (Eli Lilly) from soil bacteria Treat Gram-positive bacteria Drug of Last Resort –Intravenous –Resistance Roughly 1000x less bioactivity 2
4
Retrosynthesis 5 amide bonds / 5 peptide couplings, 6 alpha-AA derivatives Atropodiastereomers, –DE = 18.7 kcal/mol –AB = 25.1 kcal/mol –CD = 30.4 kcal/mol Cyclization order, CD, AB, DE –Permits recycling of undesired atropisomer… thermal equilibration Biaryl, 2 nucleophilic substitutions –Formation CD / DE Activating nitro also serves as a precursor for arylchloride 3
5
Ring A Formation 4 Dale L. Boger. J. Am. Chem. Soc. 1999, 121, 10004-10011
6
Ring B Formation 5 Boger, Dale L. Bioorg. Chem. Lett. 1995, 5, 3091-3096
7
Ring C 6 Vassil P. Vassilev. Tet. Lett. 1995, 36, 4081-4084
8
Ring D: Chiral Auxilary 7 Nsenda, T. Tet. Lett. 1998, 39,2191
9
Ring E 8 Boger, Dale L. Bioorg. Chem. Lett. 1995, 5, 3091-3096 Boger, Dale L. J. Org. Chem. 1997, 62, 4721-4736
10
Ring E 9 Unlisted RXN
11
Ring D 10 Dale. L. Boger. J. Am. Chem. Soc. 1997, 62, 4721
12
BCD Synthesis 11
13
BCD Synthesis 12
14
ABCD Synthesis 13 Thermal equilibration of product @ 230 o C not seen
15
ABCD Synthesis 14 Thermal equilibration of product @ 170 o C not seen
16
ABCD Synthesis: Suzuki Coupling 15
17
ABCD Cyclization 16
18
ABCD Cyclization 17
19
ABCDE Synthesis 18
20
ABCDE Cyclization 19 Again, no thermal equilibration
21
ABCDE 20
22
Final Stretch 21 Global deprotection 4 aryl esters, 2 TBS, NBoc, and 4-methyl carbamate!
23
Conclusion Product binds to D Ala- D Lac –100 fold increase Product binds to D Ala- D Ala –10 fold decrease 22
24
Thank You 23 Dale. L. Boger. J. Am. Chem. Soc. 2006, 128, 2885-2892 Dale. L. Boger. J. Am. Chem. Soc. 2003, 126, 4310-4317 - Total synth Ristocetin Dale. L. Boger. J. Am. Chem. Soc. 1999, 121, 10004-10011 - Original total synth Vancomycin Aglycon Dale. L. Boger. J. Org. Chem. 1997, 62, 4721-4736 Dale. L. Boger. Bioorg. Med. Chem. Lett. 1995, 5, 3091-3096
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.